Hexagon Bio

Hexagon Bio

Hexagon Bio

Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics.
Founded
2016
Raised
$47M
Follow us
Alexa global traffic share
Latest funding
$47,000,000
Venture capital (Series A) - 2020
Team Size
1–10
Employees
FinSMEs

Hexagon Bio Closes $47M Series A Financing

$47,000,000 Venture capital (Series A)
Forbes Tech

This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi